Assessment and Prevalence of Communicable and Non-Communicable Diseases and their Risk Factors in Adults

Authors

  • Urooj Arif
  • Shaik Aamena Thanveer
  • P Rakshitha
  • N Gowtham
  • Amatul Ali Sameera
  • Nazia Lateef Amrohi

DOI:

https://doi.org/10.52783/jns.v14.3279

Keywords:

Lower Respiratory Tract Infection, Dengue, Pneumonia, Hypertension

Abstract

Aim and objectives: To perform a prospective study on assessment of occurrence of communicable and non-communicable diseases and study their risk factors in adults.

Methodology: The study was conducted at Aware Gleneagles global hospitals in L.B. Nagar, Hyderabad, over a 6 months period among 115 subjects in the study. Patients of both genders age between 18 to 55 years and comorbidities were included in the study. Patients with OP patients, pregnant patients, patients on other medication systems (ayurvedic, Unani and homeopathy), neonates were excluded from the study. Any patient with comorbidities who are at risk of developing communicable or non-communicable diseases had their information collected using a data collection form that included patient’s demographics, prescription charts, laboratory investigations, medical history and other required information.

Result: A study of 115 patient records revealed a demographic split of 60 males (52.2%) and 55 females (47.8%). The data showed 50 cases (43.5%) of communicable diseases and 65 cases (56.5%) of non-communicable diseases. Notably, 65 patients had comorbid conditions, primarily hypertension and diabetes. The 51-55 age group was disproportionately affected by both communicable and non-communicable diseases. Pseudomonas aeruginosa was identified as the most common microorganism causing Lower Respiratory Tract Infections (LRTI). The most prevalent communicable diseases were viral pyrexia and LRTI, while Urinary Tract Infections (UTI) and acute gastroenteritis were the most common non-communicable diseases. Overall, the study found a higher incidence of communicable diseases compared to non-communicable diseases.

Conclusion: This study examined 115 subjects affected by diverse communicable and non-communicable diseases, revealing varying prevalence rates among the participants over the study period.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Baridalyne Nongkynrihs, BK Patro, Chandrakanta S Pandav: Current Status of Communicable and Non-communicable Diseases in India; Journal of the association of physician of India.2003 Dec 31;118-123.

Theodore H Tulchinsky, Elena A Varacikova: Communicable diseases; The New Public Health. 2014 Oct 10;149-236.

Harsh Mohan. Chapter 6: Infectious and Parasitic Diseases. In: Harsh Mohan, Textbook of Pathology, 7th Edition (2015). P.175

Teddy Namirimu, Sunjoo Kim: Dengue fever: epidemiology, clinical manifestations, diagnosis, and therapeutic strategies; Annals of Clinical Microbiology.2024 May 20;131-141.

Joseph. T. Dipiro. Chapter 47: Viral Hepatitis. In: Joseph. T. Dipiro, Pharmacotherapy – A Pathophysiologic Approach, 8th Edition (2011). P. 685

Joseph. T. Dipiro. Chapter 47: Viral Hepatitis. In: Joseph. T. Dipiro, Pharmacotherapy – A Pathophysiologic Approach, 8th Edition (2011). P. 687

Joseph. T. Dipiro. Chapter 47: Viral Hepatitis. In: Joseph. T. Dipiro, Pharmacotherapy – A Pathophysiologic Approach, 8th Edition (2011). P. 689

Joseph. T. Dipiro. Chapter 47: Viral Hepatitis. In: Joseph. T. Dipiro, Pharmacotherapy – A Pathophysiologic Approach, 8th Edition (2011). P. 692

Joseph. T. Dipiro. Chapter 47: Viral Hepatitis. In: Joseph. T. Dipiro, Pharmacotherapy – A Pathophysiologic Approach, 8th Edition (2011). P. 696

Hui-Chun Li, Shih-Yen Lo: Hepatitis C virus: Virology, diagnosis and treatment. World Journal of Hepatology.2015 March 30;1377-1389.

Stéphanie Pascarella, Francesco Negro: Hepatitis D virus: an update. Liver International.2010 July 6

Krzysztof Krawczynski: Hepatitis E; Hepatology. volume 17 1992 Dec 11: 932-941.

Roger Walker and Cate Whittlesea. Chapter 40: Tuberculosis. In: Roger Walker and Cate Whittlesea, Clinical Pharmacy and Therapeutics, 5th Edition (2012). P. 608

K D Tripathi. Chapter 56: Anti-Tubercular Drugs. In: K D Tripathi, Essentials of Medical Pharmacology, 8th Edition (2019). P. 825

K D Tripathi. Chapter 56: Anti-Tubercular Drugs. In: K D Tripathi, Essentials of Medical Pharmacology, 8th Edition (2019). P. 816

Uttam Kumar Paul, Arup Bandyopadhyay: Typhoid fever: International Journal of Advances in Medicine; 2017 March 2;300-306.

Roger Walker and Cate Whittlesea. Chapter 35: Pneumonia. In: Roger Walker and Cate Whittlesea, Clinical Pharmacy and Therapeutics, 5th Edition (2012). P. 550

Roger Walker and Cate Whittlesea. Chapter 35: Pneumonia. In: Roger Walker and Cate Whittlesea, Clinical Pharmacy and Therapeutics, 5th Edition (2012). P. 551

Roger Walker and Cate Whittlesea. Chapter 35: Pneumonia. In: Roger Walker and Cate Whittlesea, Clinical Pharmacy and Therapeutics, 5th Edition (2012). P. 552

Cate Whittlesea, Karen Hodson. Chapter 36: Influenza. In: Cate Whittlesea, Karen Hodson, Clinical Pharmacy and Therapeutics,6thEdition (2019). P. 608

21.Roger Walker and Cate Whittlesea. Chapter 35: Influenza. In: Roger Walker and Cate Whittlesea, Clinical Pharmacy and Therapeutics, 5th Edition (2012). P. 547

Roger Walker and Cate Whittlesea. Chapter 41: AIDS. In: Roger Walker and Cate Whittlesea, Clinical Pharmacy and Therapeutics, 5th Edition (2012). P. 621

K D Tripathi. Chapter 60: Anti-Viral Drugs. In: K D Tripathi, Essentials of Medical Pharmacology, 8th Edition (2019). P. 861

Roger Walker and Cate Whittlesea. Chapter 36: UTI. In: Roger Walker and Cate Whittlesea, Clinical Pharmacy and Therapeutics, 5th Edition (2012). P. 561

Roger Walker and Cate Whittlesea. Chapter 36: UTI. In: Roger Walker and Cate Whittlesea, Clinical Pharmacy and Therapeutics, 5th Edition (2012). P. 568

Harsh Mohan. Chapter 15: The Respiratory System. In: Harsh Mohan, Text Book of Pathology, 7th Edition (2015). P.458

Roger Walker and Cate Whittlesea. Chapter 35: Respiratory Infections. In: Roger Walker and Cate Whittlesea, Clinical Pharmacy and Therapeutics, 5th Edition (2012). P. 550

Joseph. T. Dipiro. Chapter 83: Diabetes Mellitus. In: Joseph. T. Dipiro, Pharmacotherapy – A Pathophysiologic Approach, 8th Edition (2011). P. 1255

KD Tripathi. Chapter 19: Insulin, Oral Anti-Diabetic Drugs and Glucagon. In KD Tripathi: Essentials of Medical Pharmacology, 8th Edition (2019). P. 294

Joseph. T. Dipiro. Chapter 33: Asthma In: Joseph. T. Dipiro, Pharmacotherapy – A Pathophysiologic Approach, 8th Edition (2011). P. 439

Joseph. T. Dipiro. Chapter 33: Asthma In: Joseph. T. Dipiro, Pharmacotherapy – A Pathophysiologic Approach, 8th Edition (2011). P. 448

Roger Walker and Cate Whittlesea. Chapter 20: Coronary Heart Disease. In: Roger Walker and Cate Whittlesea, Clinical Pharmacy and Therapeutics, 5th Edition (2012). P. 312

KD Tripathi. Chapter 40: Anti-Anginal and other Anti-Ischemic Drugs. In: KD Tripathi,Essentials of Medical Pharmacology, 8th Edition (2019). P. 585

Joseph. T. Dipiro. Chapter 51: Acute Kidney Injury In: Joseph. T. Dipiro, Pharmacotherapy – A Pathophysiologic Approach, 8th Edition (2011). P. 742

Joseph. T. Dipiro. Chapter 51: Acute Kidney Injury In: Joseph. T. Dipiro, Pharmacotherapy – A Pathophysiologic Approach, 8th Edition (2011). P. 751

Joseph. T. Dipiro. Chapter 27: Stoke In: Joseph. T. Dipiro, Pharmacotherapy – A Pathophysiologic Approach, 8th Edition (2011). P. 353

Joseph. T. Dipiro. Chapter 27: Stoke In: Joseph. T. Dipiro, Pharmacotherapy – A Pathophysiologic Approach, 8th Edition (2011). P. 358

Alemu Belayneh, Legese Chelkeba, Firehiwot Amare Henok Fisseha, Senbeta Guteta Abdissa, Mirgissa Kaba, Shivani A. Patel and Mohammed K. Ali: Investigation of non-communicable diseases prevalence, patterns, and patient outcomes in hospitalized populations: a prospective observational study in three tertiary hospitals; Journal of health, population and nutrition.2024; 1-11.

Fariba Tohidinezhad, Ali Khorsand, Seyed Rasoul Zakavi, Reza Rezvani, Siamak Zarei-Ghanavati, Majid Abrishami, Ali Moradi, Mahmoud Tavakoli, Donya Farrokh, Masoud Pezeshki Rad, Bita Abbasi, Mitra Ahadi, Lahya Afshari Saleh, Mohammad Tayebi, Mahnaz Amini, Hossein Poustchi, Ameen Abu-Hanna and Saeid Eslami: The burden and predisposing factors of non-communicable diseases in Mashhad University of Medical Sciences personnel: a prospective 15-year organizational cohort study protocol and baseline assessment; BMC Public Health.2020 Oct 14;1-15.

Meghnath Dhimal, Khem Bahadur Karki, Sanjib Kumar Sharma, Krishna Kumar Aryal, Namuna Shrestha,Anil Poudyal, Namra Kumar Mahato, Ashwin Karakheti, Milesh Jung Sijapati, Puspa Raj Khanal, Suresh Mehata, Abhinav Vaidya, Binod Kumar Yadav, Krishna Prasad Adhikary, Anjani Kumar Jha: Prevalence of Selected Chronic Non-Communicable Diseases in Nepal; J Nepal Health Res Counc.2019 Jul-Sep;394-401.

Hadiati Setyorini, Artaria Tjempakasari, Nunuk Mardiana: Risk Factors for Urinary Tract Infection in Hospitalized Patients; Biomolecular and Health Science Journal.2019 June 10;4-8.

Song Zhang, Zheng Liu, Yong-Liang Liu, Yu-Ling Wang, Tao Liu1 and Xiang-Bin Cui: Prevalence of stroke and associated risk factors among middle-aged and older farmers in western China; Environmental Health and Preventive Medicine.2017 March 4; 1-6.

A. Bharath Kumar, Dr. S. Chandra Babu, V. Vinod Kumar, K. Vyshnavi Bai, P. V. Harish5 C. Gopinath: Assessment of types of fevers in tertiary care hospital; World Journal of Pharmaceutical Research.2016 Feb 29;1681-1689.

Tarek Tawfik Amin, Ali Ibrahim Al Sultan, Ola Abdelmoniem Mostafa, Amr, Ahmed Darwish, Mohamed Rashad Al-Naboli: Profile of Non-Communicable Disease Risk Factors Among Employees at a Saudi University; Asian Pacific Journal of Cancer Prevention.2014 ;7897-7907.

T Sekhri, R S Kanwar, R Wilfred, P Chugh,M Chhillar, R Aggarwal,Y K Sharma, J Sethi, J Sundriyal, K Bhadra, S Singh,N Rautela, Tek Chand,M Singh, S K Singh: Prevalence of risk factors for coronary artery disease in an urban Indian population; BMJ open.2014 Aug 20;1-7.

Aroor Bhagyalaxmi, Trivedi Atul, Jain Shikha: Prevalence of Risk Factors of Non-communicable Diseases in a District of Gujarat, India; Journal of health population and nutrition.2013 March ;78-85.

Helena Nordenstedt, David Y Graham, Jennifer R Kramer, Massimo Rugge, Gordana Verstovsek, Stephanie Fitzgerald, Abeer Alsarraj, Yasser Shaib, Maria E Velez, Neena Abraham, Bhupinderjit Anand, Rhonda Cole, Hashem B El-Serag: Helicobacter pylori -Negative Gastritis: Prevalence and Risk Factors; AM J Gastroenterol.2013 Jan;65-71.

Downloads

Published

2025-04-09

How to Cite

1.
Arif U, Thanveer SA, Rakshitha P, Gowtham N, Sameera AA, Amrohi NL. Assessment and Prevalence of Communicable and Non-Communicable Diseases and their Risk Factors in Adults. J Neonatal Surg [Internet]. 2025Apr.9 [cited 2025Nov.5];14(13S):522-3. Available from: https://mail.jneonatalsurg.com/index.php/jns/article/view/3279